Rigel Pharmaceuticals RIGL Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's accrued manufacturing costs?
- Rigel Pharmaceuticals (RIGL) reported accrued manufacturing costs of $6.01M in Q1 2026.
- How has Rigel Pharmaceuticals's accrued manufacturing costs changed year-over-year?
- Rigel Pharmaceuticals's accrued manufacturing costs decreased by 0.2% year-over-year, from $6.02M to $6.01M.
- What is the long-term trend for Rigel Pharmaceuticals's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's accrued manufacturing costs has grown at a 4.4% compound annual growth rate (CAGR), from $9.59M to $11.91M.